14th edition

Format
HYBRID

December 2nd & 3rd, 2025

IN-PERSON | STRASBOURG

December 8th ,2025

ONLINE MEETINGS

14th edition

Format
HYBRID

December 2nd & 3rd, 2025

IN-PERSON | STRASBOURG

December 8th ,2025

ONLINE MEETINGS

Madiha Derouazi

Founder and CEO
SwitzerlandAMAL Therapeutics

Madiha Derouazi has been working on vector engineering and therapeutic cancer vaccines for over 12 years. She has a strong background in applied molecular and cellular biotechnology, with research interests at the interface of fundamental and translational research. Madiha Derouazi holds a PhD in Biotechnology from the Ecole Polytechnique Fédérale de Lausanne (EPFL), Switzerland and a Master in Biotechnology Engineering from the University of Technology of Berlin, Germany.

Scroll to Top
  • No products in the cart.